Power of suggestion revealed in study of migraine drug - NewsChannel5.com | Nashville News, Weather & Sports

Power of suggestion revealed in study of migraine drug

Updated:

By Mary Brophy Marcus
HealthDay Reporter

WEDNESDAY, Jan. 8, 2014 (HealthDay News) -- A new study of migraine sufferers suggests that what you're told when your doctor prescribes medication can influence your body's response to it.

Researchers from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston compared the effects of a common migraine drug and an inactive placebo in 66 people who suffer from migraines. The condition includes throbbing headache, nausea, vomiting and sensitivity to light and sound.

The results consistently showed that taking the pills accompanied by positive information increased the effectiveness of the treatment, whether the patient had taken the real deal -- the drug Maxalt -- or a pill labeled "placebo."

Headache specialist Dr. Andrew Charles said the study demonstrates that expectation about response plays an important role in the ultimate response to a treatment.

"When migraine patients were told by their doctor that a pill would help ease their headaches, this advice seemed to produce results whether or not the pill was a real migraine medication or a dummy placebo," said Charles, professor and director of the headache research and treatment program in the department of neurology at University of California School of Medicine, Los Angeles.

"Relief was still higher with the actual medicine, so drugs do work beyond the placebo effect, but the researchers say that the placebo effect may still account for half of the therapeutic value of a drug," said Charles, who was not involved in the research.

For the study, published online Jan. 8 in the journal Science Translational Medicine, the scientists studied more than 450 migraine attacks in the study participants, following them over seven separate episodes.

To establish a baseline, each person was asked to report their pain and symptoms 30 minutes after the onset of an unmedicated migraine episode, and again 2.5 hours after its onset.

Each participant then received six treatment envelopes. The envelopes were labeled in one of three ways: "Maxalt" (rizatriptan); "placebo"; or "Maxalt or placebo." The labels were true for four attacks and false for two attacks.

The three situations were labeled by the researchers as positive (meaning a drug that could help with migraine symptoms was provided), negative (meaning no drug, only a placebo pill was provided), or neutral (meaning it was unknown if the drug or placebo pill was within the envelope). But for two situations, one of the "Maxalt" envelopes actually held a placebo and one of the "placebo" envelopes contained Maxalt.

The participants were asked to self-report their responses to treatment over the course of their next six migraine episodes.

Dr. Ted Kaptchuk, a senior author of the study, said that even though Maxalt was superior to the placebo in terms of alleviating pain, "we found that under each of the three messages, the placebo effect accounted for at least 50 percent of the subjects' overall pain relief."

When Maxalt was labeled "Maxalt," the patients' reports of pain relief more than doubled compared to when Maxalt was labeled "placebo," said Kaptchuk, a professor of medicine at Harvard. "This tells us that the effectiveness of a good pharmaceutical may be doubled by enhancing the placebo effect," he said.

When patients received Maxalt labeled as placebo, they were being treated by the medication but without any positive expectation, the other senior author, Rami Burstein, a professor of medicine at Harvard, said in a Beth Israel news release. "This was an attempt to isolate the pharmaceutical effect of Maxalt from any placebo effect," Burstein said.

The authors were surprised to find that even when patients were given a placebo labeled as "placebo," they reported pain relief, compared with no treatment.

"We don't know what that's about. It's a novel finding," added Kaptchuk.

Charles said the study was interesting and confirms what many experts believe about the placebo effect. "It's more rigorous than perhaps a number of the other studies that have been done previously," he noted.

Could these results play out across the spectrum of medical care?

"Obviously we don't know, we only looked at migraine," said Kaptchuk, "but I think that in many categories of illness and drugs, this would be proof of concept.

"This is likely to be operating in many other conditions, especially in conditions like nausea or irritable bowel syndrome, where a person's illness is defined by self-report," he added. "Self-reporting is a big part of what people feel."

More research will be needed to explore how these findings could be applied to clinical care and to learn more about how placebos might help boost drug treatment care, Kaptchuk said.

Some research has suggested that simply hearing the words of medicine can have a healing effect, he noted.

The study was partly funded by Merck and Co., the maker of Maxalt.

More information

The U.S. National Library of Medicine has more about migraine.

Copyright © 2014 HealthDay. All rights reserved.

  • Medical News HeadlinesMedical News HeadlinesMore>>

  • Migraine Relief: Stopping Pain & Relieving Pressure

    Migraine Relief: Stopping Pain & Relieving Pressure

    Friday, April 18 2014 5:15 PM EDT2014-04-18 21:15:06 GMT
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
  • Hope For Lanie: Curing SMA

    Hope For Lanie: Curing SMA

    Thursday, April 17 2014 5:15 PM EDT2014-04-17 21:15:09 GMT
    SMA attacks the body's motor neurons and causes paralysis. There is no cure, but for the first time doctors are studying an experimental therapy that targets more than just symptoms.more>>
    SMA attacks the body's motor neurons and causes paralysis. There is no cure for SMA but for the first time doctors are studying an experimental therapy that targets more than just symptoms, it targets mutated SMN genes, which are responsible for SMA.more>>
  • Washing Lungs & Breathing Better

    Washing Lungs & Breathing Better

    Wednesday, April 16 2014 5:15 PM EDT2014-04-16 21:15:09 GMT
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
  • Ocular Melanoma: Saving Lives, Saving Eyes

    Ocular Melanoma: Saving Lives, Saving Eyes

    Friday, April 11 2014 5:15 PM EDT2014-04-11 21:15:07 GMT
    Ocular melanoma, also called uveal melanoma, is a rare type of melanoma that targets the eye. It can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
    Ocular melanoma, also called uveal melanoma, is a type of melanoma that targets the eye. It affects about 2,000 people a year in the United States. Although rare – it can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
  • Memory Palace: Coping With Chemo Brain

    Memory Palace: Coping With Chemo Brain

    Thursday, April 10 2014 5:15 PM EDT2014-04-10 21:15:09 GMT
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
  • Pedaling For A Cure

    Pedaling For A Cure

    Wednesday, April 9 2014 5:15 PM EDT2014-04-09 21:15:09 GMT
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
  • Bringing Hearts Back To Life: New Improved Defibrillator

    Bringing Hearts Back To Life: New Improved Defibrillator

    Tuesday, April 8 2014 5:15 PM EDT2014-04-08 21:15:13 GMT
    CPR and a portable defibrillator helped keep Eric Robinson alive after he went into cardiac arrest. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
    A year ago, while jamming with his son's band, Eric Robinson went into cardiac arrest. CPR and a portable defibrillator helped keep Robinson alive. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
  • Helping High Risk Hearts

    Helping High Risk Hearts

    Monday, April 7 2014 5:15 PM EDT2014-04-07 21:15:09 GMT
    Ironing is not exactly Barbara Roy's favorite activity, but it's something she's glad she can do again. Her doctor diagnosed her with severe aortic stenosis.more>>
    Ironing is not exactly Barbara Roy's favorite activity, but it's something she's glad she can do again. Her doctor diagnosed her with severe aortic stenosis.more>>
  • Hernias In Newborns: Lincoln's Story

    Hernias In Newborns: Lincoln's Story

    Friday, April 4 2014 5:15 PM EDT2014-04-04 21:15:07 GMT
    Congenital diaphragmatic hernias occur in about one in every 2,000 births. They can be deadly, but now doctors are using a more aggressive treatment approach.more>>
    Congenital diaphragmatic hernias occur in about one in every 2,000 births. They can be deadly, but now doctors are using a more aggressive treatment approach.more>>
  • Predicting Bad Hearts

    Predicting Bad Hearts

    Thursday, April 3 2014 5:15 PM EDT2014-04-03 21:15:09 GMT
    Every year, more than 700,000 Americans have a heart attack. Now, researchers at Baylor Research Institute at Dallas have uncovered a biomarker that may help them spot the disease sooner.more>>
    Every year, more than 700,000 Americans have a heart attack. And 600,000 die of heart disease. Now, researchers at Baylor Research Institute at Dallas have uncovered a biomarker that may help them spot the disease sooner; and they did it by pure accident.more>>
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
Powered by WorldNow
All content © Copyright 2000 - 2014 NewsChannel 5 (WTVF-TV) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.